CervoMed (CRVO) Analyst & Key Data

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

7

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.57

Median Target+493.39%

$15.25

Potential upside vs current price

DCF Value-68.74%

$0.80

Potential downside vs current price

Current Stock Price

$2.57

Median Target+493.39%

$15.25

Potential upside vs current price

DCF Value-68.74%

$0.80

Potential downside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

7

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.57

Median Target+493.39%

$15.25

Potential upside vs current price

DCF Value-68.74%

$0.80

Potential downside vs current price

Current Stock Price

$2.57

Median Target+493.39%

$15.25

Potential upside vs current price

DCF Value-68.74%

$0.80

Potential downside vs current price

CervoMed Inc.